Dashboard
Manage Tickers

GPCR


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-reiterates-market-outperform-on-structure-therapeutics-maintains-91-price-target
JMP Securities Reiterates Market Outperfor...
05/10/2024 16:50:39

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

structure-therapeutics-q1-eps-019-beats-021-estimate
Structure Therapeutics Q1 EPS $(0.19) Beat...
05/09/2024 22:41:34

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate o...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/03/2024 15:22:18

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:53:16

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-initiates-coverage-on-structure-therapeutics-with-overweight-rating-announces-price-target-of-65
Cantor Fitzgerald Initiates Coverage On St...
04/09/2024 11:03:21

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Overweight ratin...

jmp-securities-reiterates-market-outperform-on-structure-therapeutics-maintains-91-price-target
JMP Securities Reiterates Market Outperfor...
03/08/2024 18:02:55

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

structure-therapeutics-reports-year-end-cash-balance-of-4673m
Structure Therapeutics Reports Year-End Ca...
03/08/2024 13:41:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/19/2023 13:07:32

nasdaq-gains-100-points-biomerica-shares-spike-higher
Nasdaq Gains 100 Points; Biomerica Shares ...
12/18/2023 19:21:38

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The D...

why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Lantheus Holdings Shares Are Trading L...
12/18/2023 18:05:04

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
12/18/2023 17:32:13

crude-oil-rises-3-us-housing-market-index-increases-in-december
Crude Oil Rises 3%; US Housing Market Inde...
12/18/2023 17:17:23

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded ...

why-is-novo-nordisks-potential-obesity-drug-rival-structure-therapeutics-stock-tanking-today
Why Is Novo Nordisk's Potential Obesity Dr...
12/18/2023 16:20:41

Structure Therapeutics Inc (NASDAQ: GPCR) shares are trading lower after the company provided a comprehensive development progr...

dow-gains-over-50-points-nippon-steel-to-acquire-u-s-steel
Dow Gains Over 50 Points; Nippon Steel To ...
12/18/2023 14:51:14

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 50 points on Monday. Following the market open...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
12/18/2023 13:08:00

structure-therapeutics-provides-comprehensive-gsbr-1290-program-update-including-clinically-meaningful-proof-of-concept-data-from-phase-2a-clinical-study
Structure Therapeutics Provides Comprehens...
12/18/2023 12:35:58

Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecu...

jmp-securities-reiterates-market-outperform-on-structure-therapeutics-maintains-91-price-target
JMP Securities Reiterates Market Outperfor...
11/20/2023 14:16:58

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

what-6-analyst-ratings-have-to-say-about-structure-therapeutics
What 6 Analyst Ratings Have To Say About S...
11/15/2023 19:00:48

jmp-securities-maintains-market-outperform-on-structure-therapeutics-raises-price-target-to-91
JMP Securities Maintains Market Outperform...
11/15/2023 17:50:23

JMP Securities analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and raises ...

structure-therapeutics-eps-021-up-from-127-yoy
Structure Therapeutics EPS $(0.21) Up From...
11/14/2023 22:12:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION